⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Cell and Gene Therapy Market Projected to Reach US$ 183.1 Billion by 2035, Supported by Expanding Global Clinical Trial Activity Says Astute Analytica
globenewswire.com
NVS
ABBV
BNTX
LLY
BMY
GILD
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic Collaborations - ResearchAndMarkets.com
businesswire.com
MRK
BMY
AZN
JNJ
NVS
Regenexx Pain Solution Center Bangladesh Launches Advanced Regenerative Rheumatology Program, Introducing Breakthrough Non-Surgical Pain Relief and Autoimmune Care In Bangladesh & Globally
accessnewswire.com
NVS
PFE
AZN
ABBV
LLY
GSK
AMGN
Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence
prnewswire.com
EDIT
NTLA
RPTX
NVS
GILD
BMY
VRTX
CRL
OCGN
IMG Saxe-Anhalt : 2026 en vue - La Saxe-Anhalt donne le ton pour les industries du futur USA - Français USA - English USA - English APAC - English Korea - 한국어 USA - Deutsch
prnewswire.com
NVS
AVT
DTG
IMG Sachsen-Anhalt: 2026 in Sicht - Sachsen-Anhalt gibt die Richtung für Zukunftsindustrien vor USA - Deutsch USA - English USA - English APAC - English Korea - 한국어
prnewswire.com
NVS
AVT
DTG
IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries USA - English USA - English
prnewswire.com
NVS
AVT
DTG
IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
prnewswire.com
NVS
AVT
DTG
Novartis and US government reach agreement on lowering drug prices in the US
globenewswire.com
NVS
Digital Manufacturing in Life Sciences Market to Reach USD 177.5 Billion by 2035, Leading at 15.6% CAGR by 2035
globenewswire.com
AZN
SI
HON
AMZN
PFE
NVS
JNJ
GEHC
CAR